Why Become an ASA Corporate Supporter?
The American Society of Anesthesiologists is pleased to offer the ASA Corporate Supporter Program. ASA believes in forming collaborative relationships with corporate supporters so that each of us can appropriately leverage the important work of the other.
Founded in 1905, the American Society of Anesthesiologists is the premier anesthesiology professional society. With approximately 50,000 members, ASA represents more than 80 percent of all practicing anesthesiologists in the United States. ASA leads through innovation in patient safety, clinical care, advocacy, education and research.
The Society's top priority is to raise and maintain the standard of the medical practice of anesthesiology and improve patient care. ASA's educational activities cover the full continuum of an anesthesiologist's practice. ASA's history of providing high-quality continuing medical education programming long precedes its initial accreditation by ACCME in 1988.
The overall business climate in the United States, and specifically in the health care industry, continually presents new challenges and opportunities. ASA is committed to working alongside its members, leaders and company representatives to adapt and provide leadership to our specialty and its stakeholders. By collaborating together and sharing expertise, both ASA and its corporate supporters can better serve and communicate with the anesthesiology community.
ASA Corporate Supporter Program Benefits:
- Exclusive opportunities for networking and year-round visibility.
- Clear and consistent positioning of ASA corporate relationships to internal and external audiences.
- Increased parity between the investment made and the value received for marketing commitments.
- Increased value for ASA and its members through more meaningful relationships.
- New opportunities to develop relevant engagement and connections to the membership.
For more information about becoming an ASA Corporate Supporter, please contact Sara Moser, Director of Corporate Development, at (847) 268-9230 or by e-mail.
What do ASA Corporate Supporters say?
"Teleflex is dedicated to partnering with anesthesiologists to provide solutions that help minimize risk and maximize outcomes. We are honored to support ASA through the Industry Supporter program to promote education and programs that benefit patients and providers."
- Cary G. Vance, Executive Vice President, Teleflex - North America
"We are proud to support ASA and its members to promote high quality and safe patient care. PharMEDium is built around the idea of putting patient safety first and recognizing that quality can be attained by people and an organization that are dedicated and passionate to its pursuit."
– David N. Jonas, Chairman and CEO, PharMEDium
"As a leading global provider of anesthetic products, Baxter is highly committed to our mission of advancing the field of anesthesiology through education and research support. We're proud to be the first industry representative in the program and look forward to supporting the ASA's commitment to leadership and education in the anesthesia community."
– Bob Davis, General Manager of the Global Anesthesia and Critical Care business at Baxter International.
"Surgical Information Systems (SIS) is dedicated to advancing the practice of anesthesiology by providing solutions that allow ASA members to improve operational efficiencies, regulatory compliance, patient safety, and financial performance. We are proud to be the first AIMS provider to participate as an ASA Industry Supporter and we look forward to the opportunity to support the ASA in future initiatives."
– Ed Daihl, CEO, Surgical Information systems
"ASA is globally recognized for advancing patient safety and supporting the use of modern pharmaceuticals and technologies to improve patient outcomes. Hospira, a leading provider of injectable anesthetic drugs, is pleased to support the ASA's dedication to patient safety and looks forward to helping ASA in its mission to advance the field of anesthesiology through education, research and clinical leadership."
– Kelly Glivar, Vice President and General Manager, Acute Care Proprietary Pharma, Hospira